Intratumor Heterogeneity Assessed by 18F-FDG PET/CT Predicts Treatment Response and Survival Outcomes in Patients with Hodgkin Lymphoma
Kun-Han Lue,Yi-Feng Wu,Shu-Hsin Liu,Tsung-Cheng Hsieh,Keh-Shih Chuang,Hsin-Hon Lin,Yu-Hung Chen
DOI: https://doi.org/10.1016/j.acra.2019.10.015
IF: 5.482
2020-08-01
Academic Radiology
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Rationale and Objectives</h3><p>Radiomic analysis of <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography (<sup>18</sup>F-FDG PET/CT) images enables the extraction of quantitative information of intratumour heterogeneity. This study investigated whether the baseline <sup>18</sup>F-FDG PET/CT radiomics can predict treatment response and survival outcomes in patients with Hodgkin lymphoma (HL).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Materials and Methods</h3><p>Thirty-five patients diagnosed with HL who underwent <sup>18</sup>F-FDG PET/CT scans before and during chemotherapy were retrospectively enrolled in this investigation. For each patient, we extracted 709 radiomic features from pretreatment PET/CT images. Clinical variables (age, gender, B symptoms, bulky tumor, and disease stage) and radiomic signatures (intensity, texture, and wavelet) were analyzed according to response to therapy, progression-free survival (PFS), and overall survival (OS). Receiver operating characteristic curve, logistic regression, and Cox proportional hazards model were used to examine potential predictive and prognostic factors.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>High-intensity run emphasis (HIR) of PET and run-length nonuniformity (RLNU) of CT extracted from gray-level run-length matrix (GLRM) in high-frequency wavelets were independent predictive factors for the treatment response (odds ratio [OR] = 36.4, <em>p</em> = 0.014; OR = 30.4, <em>p</em> = 0.020). Intensity nonuniformity (INU) of PET and wavelet short run emphasis (SRE) of CT from GLRM and Ann Arbor stage were independently related to PFS (hazard ratio [HR] = 9.29, <em>p</em> = 0.023; HR = 18.40, <em>p</em> = 0.012; HR = 7.46, <em>p</em> = 0.049). Zone-size nonuniformity (ZSNU) of PET from gray-level size zone matrix (GLSZM) was independently associated with OS (HR = 41.02, <em>p</em> = 0.001). Based on these factors, a prognostic stratification model was devised for the risk stratification of patients. The proposed model allowed the identification of four risk groups for PFS and OS (<em>p</em> < 0.001 and <em>p</em> < 0.001).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>HIR<sub>_</sub>GLRM<sub>PET</sub> and RLNU<sub>_</sub>GLRM<sub>CT</sub> in high-frequency wavelets serve as independent predictive factors for treatment response. ZSNU<sub>_</sub>GLSZM<sub>PET</sub>, INU<sub>_</sub>GLRM<sub>PET</sub>, and wavelet SRE<sub>_</sub>GLRM<sub>CT</sub> serve as independent prognostic factors for survival outcomes. The present study proposes a prognostic stratification model that may be clinically beneficial in guiding risk-adapted treatment strategies for patients with HL.</p>
radiology, nuclear medicine & medical imaging